Healthcare Triangle Expands into Indonesia; Identifying USD 45 Million Opportunity
Company targeting Southeast Asia's largest economy with its Ezovion, Ziloy.ai and neurotechnology platforms and evaluating local partnership and joint venture...
Brain
Oculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation
Björn Tackenberg, M.D. Ph.D. FEAN FAAN, Professor of Neurology, will lead Oculis’ global integrated scientific strategy supporting the advancement of...
Glioblastoma Foundation’s Genomic Testing & Research Laboratory Now Accepting Patient Samples for Genomic Testing
The Foundation's CLIA-certified laboratory combines DNA methylation profiling, MGMT status, copy-number variation analysis and glioblastoma subtype characterization in a single...
2026 InLight Foundation Stanford Frontier Dialogue: From Nobel Optogenetics to Mind-Light Contemplation, Cross-Disciplinary Experts Explore New Frontiers in Consciousness Regulation
PALO ALTO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Following the awarding of the 2026 Nobel Prize in Physiology or...
Life with Jan Collaborates with Perrine SDA Church to Bring Renowned Physician Dr. Neil Nedley to South Florida
Free November 6–7 Community Wellness Seminar Explores Depression, Anxiety, Brain Health, and Cancer Through a Wholistic Approach to Health and...
Tovala Partners With Bryan Johnson’s Blueprint on New Longevity-Focused Meal Line
The chef-crafted line brings Blueprint's longevity protocol to Tovala, making longevity-focused nutrition easier to put into practice at homeCHICAGO, Oct....
TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd.
TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd. TME Pharma receives €150,000 for 6 months of...
ADDEX INCREASES ISSUED SHARE CAPITAL TO CREATE TREASURY SHARES
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, October 29, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq:...
Emory Researchers Identify Blood Protein Signature That Detects ALS With 98% Accuracy Using Alamar Technology
Published in Nature Communications, the study found a 10-protein signature that outperformed a leading individual ALS biomarker, including in some...
Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator Licenses SpeechDx Dataset to Eli Lilly and Company, Advancing Speech-Based Markers as a Critical Alzheimer’s Research Tool
Lilly's partnership signals growing industry recognition of AI-driven speech analysis as a path to predicting Alzheimer's disease riskNEW YORK, Oct....
Read/Write Labs™ Debuts to Build Industry-First AI Platform That Writes Code for the Brain
Expanded Executive and Advisor Team, including Jim DiCarlo, Dan Yamins and Stephen Wolfram, will Accelerate Development of Precision Therapies for...
Midi Health Takes Back “Hysterical” with a Menopause Comedy Roast Starring Michelle Buteau, Jessica Kirson, Jen Kober, and Alyce Chan
New comedy campaign roasts the symptoms women are told to live with, and points to the hormonal root cause that...
MEDSIR presents final TUXEDO-3 results highlighting the potential of patritumab deruxtecan in active brain metastases and leptomeningeal disease
The TUXEDO-3 study evaluates the efficacy of patritumab deruxtecan (HER3-DXd) for treating active brain metastases in patients with metastatic breast...
Healthcare Triangle Enters Neurotechnology AI Devices and Solutions for Southeast Asia
Malaysia and Indonesia, home to more than 310 million people with a fast-growing need for mental health care, form the...
Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence
ORION CORPORATION PRESS RELEASE 24 OCTOBER 2026 at 9.35 EEST Darolutamide plus ADT and radiation therapy reduces risk of metastasis...
BioLineRx and Hemispherian Present Preclinical Data Demonstrating Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancer at ESMO 2026
GLIX1 demonstrated reproducible synergy across different PARP inhibitors and multiple HR-proficient ovarian cancer cell lines, with high ZIP synergy scores,...
Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it will...
Founded by MIT and Flagship Alum, AI Drug Discovery Company Reflector Bio Emerges from Stealth
The New York techbio company's biological foundation model predicts a compound’s efficacy in cells, adding a complementary signal to structure-based...
NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight
DENVER, Oct. 22, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) — NeOnc Technologies Holdings (NASDAQ: NTHI) is taking its brain cancer research...
Claritas and Qubiotech join forces to build an independent challenger in quantitative PET — from whole body to brain
LONDON, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Claritas NucMed Technologies Ltd., a subsidiary of Claritas HealthTech Ltd, today announced that...